Anatolia Tani ve Biyoteknoloji Ürünleri Ar-Ge Sanayi Ticaret A.S. (IBSE: ANGEN)
Health Care · Biotechnology · TR
TL9.10
-3.09% today · -24.4% 1Y
Anatolia Tani ve Biyoteknoloji Ürünleri Ar-Ge Sanayi Ticaret A.S. (IBSE: ANGEN) operates in the Biotechnology industry within the Health Care sector. The company is valued at $41.81M.
Over the last twelve months the share price has lost 24.4%, trading between 8.94 and 16.00.
Tweenvest scores Anatolia Tani ve Biyoteknoloji Ürünleri Ar-Ge Sanayi Ticaret A.S. across four factors: quality 63/100, value 54/100, growth 67/100. Its strongest factor is growth.
ANGEN price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $41.81M
- Revenue (TTM)
- $16.02M
- P/E
- —
- EPS
- -1.17
- Dividend yield
- —
- Beta (5Y)
- 0.04
- 52-week high
- TL16.00
- 52-week low
- TL8.94
- Avg volume (3M)
- —
- Shares outstanding
- 220.00M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| AbbVie Inc.NYSE: ABBV | $469.68B | $261.29 | -1.69% |
| Amgen Inc.NasdaqGS: AMGN | $239.09B | $441.35 | -0.20% |
| Gilead Sciences, Inc.NasdaqGS: GILD | $184.47B | $148.53 | -0.16% |
| Vertex Pharmaceuticals IncorporatedNasdaqGS: VRTX | $140.13B | $549.69 | -0.57% |
| Regeneron Pharmaceuticals, Inc.NasdaqGS: REGN | $83.24B | $820.57 | -1.56% |
| argenx SEENXTBR: ARGX | $64.17B | €897.60 | +2.09% |
| Moderna, Inc.NasdaqGS: MRNA | $63.41B | $146.65 | -7.67% |
| CSL LimitedASX: CSL | $59.49B | AU$173.64 | +2.68% |
Figures last refreshed Aug 18, 2026.